New system to assess gill disease could help salmon producers
Gill disease in Atlantic salmon is caused by a number of pathogens and has different clinical and pathological signs. This means that to date, there has been no standardized methodology developed for field diagnosis, despite the fact that gill health issues are a growing concern for salmon producers in all the major salmon-producing nations.
Pharmaq News Center
New research shows that thermal and mechanical delousing techniques used…
Demand for vaccination is ever-growing in the Canadian salmon industry, and the country’s producers have made a big shift toward mechanized approaches in getting the job done.
New research on deltamethrin resistance in sea lice could help improve the effectiveness and reduce the costs of treating the global salmon industry’s “billion-dollar problem.”
Improving standards on Mediterranean fish farms is driving interest in Tricaine PHARMAQ — the only authorized fish anesthetic product.
Aquaculture in Greece has endured some ups and downs since its establishment in the 1980s, from the Greek financial crisis to the Covid-19 pandemic.
The Covid-19 pandemic has, to some extent, made epidemiologists of all of us. But for microbiologists focused on pathogens that don’t affect humans, it has created some new challenges.
The key to the continued growth of the pangasius industry is being more innovative in solving its main fish health, quality and sustainability challenges.